How Private, For-Profit Health Insurance Fails the Most Basic Test of Economics

Key Takeaways

• Health insurers earned $70 B profit in 2023 while premiums rose >50%.
• Information asymmetry prevents consumers from comparing plans at point of care.
• Adverse selection drives “death spiral,” requiring mandates or public options.
• Market concentration leaves many regions with one dominant insurer.
• Profit motive forces insurers to deny care, shifting costs to society.

Pulse Analysis

The economic foundations of health‑insurance markets were laid out by Kenneth Arrow in 1963, showing that uncertainty and information gaps make traditional competition impossible. Insurers know far more than patients about coverage limits, network rules, and prior‑authorization requirements, and consumers discover these details only when they are already sick. This asymmetry, combined with adverse selection—where the sick are most likely to buy coverage—creates a “death spiral” that only mandates, public options, or direct government provision can arrest.

Concentration amplifies these failures. Federal antitrust analyses repeatedly find that most metropolitan markets are dominated by one or two insurers, and many rural areas have a single provider. The profit‑driven model rewards denying or delaying care, shrinking networks, and raising deductibles, while premiums have surged over 50 % in the last decade. The result is job lock, higher medical‑debt‑driven bankruptcies, and costly spillovers to emergency rooms and public programs, effectively subsidizing private profit with taxpayer dollars.

International comparisons make the dysfunction stark: high‑income peers achieve better access, equity, and administrative efficiency with universal or tightly regulated multi‑payer systems, spending roughly half per‑capita of the U.S. The U.S. has chosen a political path that protects insurer profits, but the data compel a reassessment. Strengthening medical loss‑ratio rules, encouraging public options, and curbing consolidation could restore market discipline and align insurer incentives with patient outcomes, ensuring that health care serves citizens, not shareholders.